Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Mark G. Anderson · SciRah

Researcher profile · Semantic Scholar

Mark G. Anderson

Share profile

Mark G. Anderson — researcher profile on SciRah

h-index: 21
Works: 46
Citations: 3,947

Most-cited papers

ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.
C. Tse, Alexander R. Shoemaker, Jessica Adickes, Mark G. Anderson +14 more
2008Cancer Research1,895 citations Open access
Semantic Scholar
siRNA-mediated off-target gene silencing triggered by a 7 nt complementation
Xiaoyu Lin, Xiaoan Ruan, Mark G. Anderson, J. A. Mcdowell +3 more
2005Nucleic Acids Research392 citations Open access
Semantic Scholar
Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.
S. Tahir, Xiu-Fen Yang, Mark G. Anderson, S. Morgan-Lappe +8 more
2007Cancer Research317 citations Open access
Semantic Scholar
Expression of VDR and CYP24A1 mRNA in human tumors
Mark G. Anderson, M. Nakane, Xiaoan Ruan, P. Kroeger +1 more
2005Cancer Chemotherapy and Pharmacology232 citations
Semantic Scholar
ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both MET–Amplified and c-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence
Jie-Yi Wang, Mark G. Anderson, A. Oleksijew, Kedar S Vaidya +7 more
2016Clinical Cancer Research130 citations
Semantic Scholar
Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin
M. Liguori, Mark G. Anderson, S. Bukofzer, J. Mckim +4 more
2005Hepatology108 citations Open access
Semantic Scholar
Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways
X. Liu, E. Han, Mark G. Anderson, Yan Shi +14 more
2009Molecular Cancer Research99 citations Open access
Semantic Scholar
Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells
A. Sarthy, S. Morgan-Lappe, D. Zakula, Lawrence A. Vernetti +6 more
2007Molecular Cancer Therapeutics86 citations
Semantic Scholar
Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines
S. Tahir, J. Wass, M. Joseph, V. Devanarayan +7 more
2010Molecular Cancer Therapeutics74 citations
Semantic Scholar
Integrative Genomic Analysis of Small-Cell Lung Carcinoma Reveals Correlates of Sensitivity to Bcl-2 Antagonists and Uncovers Novel Chromosomal Gains
E. Olejniczak, C. van Sant, Mark G. Anderson, Gang Wang +4 more
2007Molecular Cancer Research74 citations Open access
Semantic Scholar
Identification of methods for use of formalin-fixed, paraffin-embedded tissue samples in RNA expression profiling.
Lisa R. Roberts, Jessica Bowers, Kelly Sensinger, A. Lisowski +2 more
2009Genomics65 citations Open access
Semantic Scholar
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
Jie-Yi Wang, L. Goetsch, L. Tucker, Qian Zhang +14 more
2016BMC Cancer56 citations Open access
Semantic Scholar
Bcl-XL represents a druggable molecular vulnerability during aurora B inhibitor-mediated polyploidization
O. Shah, Xiaoyu Lin, Leiming Li, Xiaoli Huang +12 more
2010Proceedings of the National Academy of Sciences of the United States of America51 citations Open access
Semantic Scholar
Endothelin signaling in osteoblasts: global genome view and implication of the calcineurin/NFAT pathway
C. van Sant, Gang Wang, Mark G. Anderson, O. J. Trask +2 more
2007Molecular Cancer Therapeutics41 citations Open access
Semantic Scholar
Sequence-specific binding of poly(ADP-ribose) polymerase-1 to the human T cell leukemia virus type-I tax responsive element.
Zhan-feng Zhang, Ellen Hildebrandt, C. Simbulan-Rosenthal, Mark G. Anderson
2002Virology39 citations Open access
Semantic Scholar
Differential Protein Analysis of Spasomolytic Polypeptide Expressing Metaplasia Using Laser Capture Microdissection and Two-dimensional Difference Gel Electrophoresis
J. R. Lee, Tammy M. Baxter, H. Yamaguchi, Timothy C. Wang +2 more
2003Applied immunohistochemistry & molecular morphology (Print)38 citations
Semantic Scholar
Nuclear Extracts Lacking DNA-dependent Protein Kinase Are Deficient in Multiple Round Transcription*
R. L. Woodard, Mark G. Anderson, W. Dynan
1999Journal of Biological Chemistry37 citations Open access
Semantic Scholar
Targeting Multiple EGFR-expressing Tumors with a Highly Potent Tumor-selective Antibody–Drug Conjugate
Mark G. Anderson, H. D. Falls, M. Mitten, A. Oleksijew +10 more
2020Molecular Cancer Therapeutics35 citations Open access
Semantic Scholar
Identification of genes that confer tumor cell resistance to the Aurora B kinase inhibitor, AZD1152
Jun Guo, Mark G. Anderson, P. Tapang, Joann P. Palma +10 more
2009The Pharmacogenomics Journal35 citations Open access
Semantic Scholar
Inhibition of Aurora B kinase sensitizes a subset of human glioma cells to TRAIL concomitant with induction of TRAIL-R2
Jun-Ling Li, Mark G. Anderson, L. Tucker, Yu Shen +2 more
2009Cell Death and Differentiation32 citations Open access
Semantic Scholar
Idiosyncratic toxicity: mechanistic insights gained from analysis of prior compounds.
J. Waring, Mark G. Anderson
2005Current opinion in drug discovery & development30 citations
Semantic Scholar
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
C. Ager, M. Reilley, C. Nicholas, Todd Bartkowiak +496 more
2016Journal for ImmunoTherapy of Cancer18 citations Open access
Semantic Scholar
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma
B. Carneiro, K. Papadopoulos, J. Strickler, A. Lassman +20 more
2022Neuro-Oncology Advances16 citations Open access
Semantic Scholar
ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition
Mark G. Anderson, Qian Zhang, Luis E. Rodriguez, Claudie Hecquet +3 more
2021BMC Cancer12 citations Open access
Semantic Scholar
A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studies
W. Gu, I. Joseph, Yi-Chun Wang, David J. Frost +21 more
2005Anti-Cancer Drugs8 citations
Semantic Scholar
Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR
Kedar S Vaidya, M. Mitten, Adelyn L. Zelaya-Lazo, A. Oleksijew +9 more
2021Journal of Neuro-Oncology7 citations
Semantic Scholar
Liquid-based Pap Smears as a Source of RNA for Gene Expression Analysis
Ellen Hildebrandt, J. R. Lee, J. H. Crosby, D. Ferris +1 more
2003Applied immunohistochemistry & molecular morphology (Print)6 citations
Semantic Scholar
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
Jie-Yi Wang, L. Goetsch, L. Tucker, Qian Zhang +14 more
2016BMC Cancer5 citations Open access
Semantic Scholar
A “Prozone-Like” Effect Influences the Efficacy of the Monoclonal Antibody ABT-700 against the Hepatocyte Growth Factor Receptor
Kedar S Vaidya, A. Oleksijew, L. Tucker, W. Pappano +10 more
2017Pharmacology4 citations
Semantic Scholar
Abstract DDT01-03: Discovery and preclinical pharmacology of JNJ-61186372: A novel bispecific antibody targeting EGFR and cMET
Sheri L. Moores, Mark L. Chiu, Barbara S. Bushey, Kristen M. Chevalier +8 more
20143 citations
Semantic Scholar
Abstract LB-312: Bispecific Centyrin simultaneously targeting EGFR and c-Met demonstrates improved activity compared to the mixture of single agents.
Donna M. Klein, S. Jacobs, M. Sheri, Mark G. Anderson +15 more
20133 citations
Semantic Scholar
Abstract B241: Bispecific antibody targeting EGFR and cMet demonstrates superior activity compared to the combination of single pathway inhibitors.
Sheri L. Moores, Mark L. Chiu, Barbara S. Bushey, Kristen M. Chevalier +10 more
20133 citations
Semantic Scholar
[17] In Vitro binding and transcription assays using the human T-cell leukemia virus type I tax protein
Mark G. Anderson, W. Dynan, Maura-Ann H. Matthews
19953 citations
Semantic Scholar
Abstract 4668: Evidence for antigen-driven TCRB chain convergence in the tumor infiltrating T cell repertoire of 85 research subjects with melanoma
T. Looney, S. Glenn, S. Pabla, J. Conroy +8 more
2018Immunology1 citations
Semantic Scholar
Abstract 2937: Utilizing multiplex chromogenic IHC and digital image analysis to evaluate immune cell content and spatial distribution within NSCLC tumor tissue
L. Sherry, Mark G. Anderson, M. Cowan, Leelavathi Dawson +2 more
20171 citations Open access
Semantic Scholar
Abstract 4707: Quantifying cellular composition using laser microdissection regions of interest via automated digital image analysis of co-registered tissue thin sections
L. Sherry, Mark G. Anderson, A. Hunt, D. Mitchell +3 more
2019Tumor Biology0 citations Open access
Semantic Scholar
Anti-prlr antibody-drug conjugates (adc) and uses thereof
E. Reilly, Mark G. Anderson
20180 citations
Semantic Scholar
Whole Slide Quantitative Image Analysis Can Demonstrate Bleomycin Induced Dose‐Dependent Increases in Fibrotic Areas Within Histologically Stained Rat Lung Tissue
A. Young, M. Mcelroy, S. Naylor, Mark G. Anderson +3 more
2017The FASEB Journal0 citations Open access
Semantic Scholar
Correlation of Nintedanib efficacy on fibrotic lesion deposition and lung function within a rat IPF model
R. Carrington, Stephen M. Jordan, Mark G. Anderson, L. Sherry +1 more
20170 citations
Semantic Scholar
Abstract 163: Evaluation of ETS2101 and its combination with anti-mCTLA4 monoclonal antibody on CD4 and CD8 TILs in a subcutaneous colorectal cancer model of CT-26
L. Sherry, Mark G. Anderson, J. Waller, Adam J. Sardar +2 more
20170 citations
Semantic Scholar
Utilisation of whole slide image analysis to quantify lesion formation, collagen content and cell density within histologically stained fibrotic lung tissue
L. Sherry, Mark G. Anderson, A. Bigley, K. McGregor +3 more
20160 citations
Semantic Scholar
Abstract P4-01-02: Prospective characterization of HER2-positive circulating tumor cells in patients with HER2-negative metastatic breast cancer
I. Krop, Erin R. Macrae, Sarah R Galler, F. Bischoff +8 more
20150 citations
Semantic Scholar
Abstract A11: Activity of a bispecific antibody targeting EGFR and cMet with enhanced Fc effector function in EGFR mutant setting with cMet pathway activation
Keri L. Soring, Katharine D. Grugan, Randall J. Breszki, J. Pardinas +10 more
20150 citations
Semantic Scholar
Abstract 1818: The Aurora B inhibitor ABT-348 is not susceptible to known resistance mechanisms of other Aurora B inhibitors
Jun Guo, M. Curtin, R. Heyman, Mark G. Anderson +13 more
20120 citations
Semantic Scholar
Abstract A161: Acquired resistance to combination treatment with TMZ and ABT‐888 is mediated by both BER and HR DNA repair pathways
X. Liu, E. Han, Mark G. Anderson, Yan Shi +14 more
20090 citations
Semantic Scholar
Identification of drug sensitivity markers in lung cancer: an integrative genomics approach
Dimitri Semizarov, E. Olejniczak, C. van Sant, Mark G. Anderson +3 more
20070 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Joann P. Palma×9
Invite
Joann P. Palma — researcher profile on SciRah
E. Reilly×9
Invite
E. Reilly — researcher profile on SciRah
A. Oleksijew×6
Invite
A. Oleksijew — researcher profile on SciRah
Kedar S Vaidya×6
Invite
Kedar S Vaidya — researcher profile on SciRah

×6

Invite

E. Boghaert — researcher profile on SciRah

Dimitri Semizarov×6

Invite

Dimitri Semizarov — researcher profile on SciRah

Invite

L. Sherry — researcher profile on SciRah

Invite

S. Tahir — researcher profile on SciRah

Invite

S. Fesik — researcher profile on SciRah

Invite

L. Tucker — researcher profile on SciRah

Invite

Qian Zhang — researcher profile on SciRah

Invite

P. Ansell — researcher profile on SciRah